Acute stroke treatment in the community: Improving our performance and expanding our options

Seminars in Neurology

Volumn 25, Issue 4, 2005, Pages 337-344

  Russman, Andrew N ^b   Katzan, Irene L ^a,b,c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Community; Quality improvement; Stroke care

Indexed keywords

CEREBROVASCULAR ACCIDENT; COMMUNITY CARE; DEMOGRAPHY; EMERGENCY HEALTH SERVICE; HEALTH CARE DELIVERY; HUMAN; METHODOLOGY; REVIEW;

CEREBROVASCULAR ACCIDENT; COMMUNITY HEALTH SERVICES; DELIVERY OF HEALTH CARE; EMERGENCY MEDICAL SERVICES; HUMANS; RESIDENCE CHARACTERISTICS;

EID: 33644833844     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-923528     Document Type: Review

References (65)

1. Elkins JS, Johnston SC. Thirty-year projections for deaths from ischemic stroke in the United States. Stroke 2003;34: 2109-2112
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587
3. Katzan IL, Hammer MD, Hixson ED, Furlan AJ, Abou-Chebl A, Nadzam DM. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol 2004;61:346-350
4. Kleindorfer D, Kissela B, Schneider A, et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke 2004;35:e27-e29
5. Arora S, Broderick JP, Frankel M, et al. Paul Coverdell Prototype Registries Writing Group. Acute stroke care in the US: results from four pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 2005;36:1232-1240
6. Cocho D, Belvis R, Marti-Fabregas J. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology 2005;64:719-720
7. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-774
8. Becker K, Fruin M, Gooding T, Tirschwell D, Love P, Mankowski T. Community-based education improves stroke knowledge. Cerebrovasc Dis 2001;11:34-43
9. Rowe AK, Frankel MR, Sanders KA. Stroke awareness among Georgia adults: epidemiology and considerations regarding measurement. South Med J 2001;94:613-618
10. Carroll C, Hobart J, Fox C, Teare L, Gibson J. Stroke in Devon: knowledge was good, but action was poor. J Neurol Neurosurg Psychiatry 2004;75:567-571
11. Pandian JD, Jaison A, Deepak SS, et al. Public awareness of warning symptoms, risk factors, and treatment of stroke in northwest India. Stroke 2005;36:644-648
12. Sug Yoon S, Heller RF, Levi C, Wiggers J, Fitzgerald PE. Knowledge of stroke risk factors, warning symptoms, and treatment among an Australian urban population. Stroke 2001;32:1926-1930
13. Schneider AT, Pancioli AM, Khoury JC, et al. Trends in community knowledge of the warning signs and risk factors for stroke. JAMA 2003;289:343-346
14. Silver FL, Rubini F, Black D, Hodgson CS. Advertising strategies to increase public knowledge of the warning signs of stroke. Stroke 2003;34:1965-1968
15. Maze LM, Bakas T. Factors associated with hospital arrival time for stroke patients. J Neurosci Nurs 2004;36:136-141, 155
16. Schroeder EB, Rosamond WD, Morris DL, Evenson KR, Hinn AR. Determinants of use of emergency medical services in a population with stroke symptoms: the Second Delay in Accessing Stroke Healthcare (DASH II) Study. Stroke 2000;31:2591-2596
17. Katzan IL, Graber TM, Furlan AJ, et al. Cuyahoga County Operation Stroke speed of emergency department evaluation and compliance with National Institutes of Neurological Disorders and Stroke time targets. Stroke 2003;34:994-998
18. Morris DL, Rosamond W, Madden K, Schultz C, Hamilton S. Prehospital and emergency department delays after acute stroke: the Genentech Stroke Presentation Survey. Stroke 2000;31:2585-2590
19. Silliman SL, Quinn B, Huggett V, Merino JG. Use of a field-to-stroke center helicopter transport program to extend thrombolytic therapy to rural residents. Stroke 2003;34:729-733
20. Kothari RU, Pancioli A, Liu T, Brott T, Broderick J. Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med 1999;33:373-378
21. Nor AM, McAllister C, Louw SJ, et al. Agreement between ambulance paramedic- and physician-recorded neurological signs with Face Arm Speech Test (FAST) in acute stroke patients. Stroke 2004;35:1355-1359
22. Kidwell CS, Starkman S, Eckstein M, Weems K, Saver JL. Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS). Stroke 2000;31:71-76
23. Llanes JN, Kidwell CS, Starkman S, Leary MC, Eckstein M, Saver JL. The Los Angeles Motor Scale (LAMS): a new measure to characterize stroke severity in the field. Prehosp Emerg Care 2004;8:46-50
24. Crocco T, Gullett T, Davis SM, et al. Feasibility of neuroprotective agent administration by prehospital personnel in an urban setting. Stroke 2003;34:1918-1922
25. Saver JL, Kidwell C, Eckstein M, Starkman S. Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke 2004;35:e106-e108
26. Marler JR, Jones PW, Emr M, eds. Rapid Identification and Treatment of Acute Stroke: Proceedings of a National Symposium. Bethesa, MD: National Institutes of Health; 1997
27. Instructions and Forms for Primary Stroke Service Designation ApplicationAvailable at: http://www.mass.gov/dph/ dhcq/stroke_app.htmAccessed March 18, 2005
28. Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 2001;32:1832-1840
29. Ruland S, Gorelick PB, Schneck M, Kim D, Moore CG, Leurgans S. Acute stroke care in Illinois: a statewide assessment of diagnostic and treatment capabilities. Stroke 2002;33:1334-1339
30. Camilo O, Goldstein LB. Statewide assessment of hospital-based stroke prevention and treatment services in North Carolina: changes over the last 5 years. Stroke 2003;34:2945-2950
31. Burgin WS, Staub L, Chan W, et al. Acute stroke care in non-urban emergency departments. Neurology 2001;57: 2006-2012
32. Morgenstern LB, Staub L, Chan W, et al. Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project. Stroke 2002;33:160-166
33. Morgenstern LB, Bartholomew LK, Grotta JC, Staub L, King M, Chan W. Sustained benefit of a community and professional intervention to increase acute stroke therapy. Arch Intern Med 2003;163:2198-2202
34. Frey JL, Jahnke HK, Goslar PW, Partovi S, Flaster MS. tPA by telephone: extending the benefits of a comprehensive stroke center. Neurology 2005;64:154-156
35. Merino JG, Silver B, Wong E, et al. Extending tissue plasminogen activator use to community and rural stroke patients. Stroke 2002;33:141-146
36. Wang DZ, Rose JA, Honings DS, Garwacki DJ, Milbrandt JC. Treating acute stroke patients with intravenous tPA: the OSF stroke network experience. Stroke 2000;31:77-81
37. Grotta JC, Burgin WS, El Mitwalli A, et al. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol 2001;58: 2009-2013
38. Audebert HJ, Kukla C, Clarmann VC, et al. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEM-PiS) in Bavaria. Stroke 2005;36:287-291
39. Handschu R, Littmann R, Reulbach U, et al. Telemedicine in emergency evaluation of acute stroke: interrater agreement in remote video examination with a novel multimedia system. Stroke 2003;34:2842-2846
40. Wang S, Gross H, Lee SB, et al. Remote evaluation of acute ischemic stroke in rural community hospitals in Georgia. Stroke 2004;35:1763-1768
41. Meyer BC. The "Stroke Team Remote Evaluation Using a Digital Observation Camera (STRokE DOC)" Telemedicine System: methods. Stroke 2005;36:494 (Abstract)
42. LaMonte MP. A comprehensive telemedicine program for stroke: The University of Maryland experience. Neurology 2005;64(suppl 1):A272 (Abstract)
43. ACEP agrees with reservations to new stroke guidelines. ACEP News 1996;3:15
44. Brott T. Thrombolysis for stroke. Arch Neurol 1996;53: 1305-1306
45. Katzan IL, Sila CA, Furlan AJ. Community use of intravenous tissue plasminogen activator for acute stroke: results of the brain matters stroke management survey. Stroke 2001;32: 861-865
46. Bravata DM, Kim N, Concato J, Krumholz HM, Brass LM. Thrombolysis for acute stroke in routine clinical practice. Arch Intern Med 2002;162:1994-2001
47. Katzan IL, Furlan AJ, Lloyd LE, et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000;283:1151-1158
48. Hill MD. The Canadian Activase for Stroke Effectiveness Study (CASES): final results. Stroke 2002;33:359 (Abstract)
49. Katzan IL, Hammer MD, Furlan AJ, Hixson ED, Nadzam DM. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update. Stroke 2003;34:799-800
50. Kleindorfer D, Hill MD, Woo D, et al. A description of Canadian and United States physician reimbursement for thrombolytic therapy administration in acute ischemic stroke. Stroke 2005;36:682-687
51. Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 2006 Rates. 42CFR Parts 205, 412, 415, 419, and 485. Centers for Medicare and Medicaid Services, Department of Health and Human Services, CMS-1500-F, 2005
52. Adams HP Jr, Brott TG, Crowell RM, et al. Guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation 1994;90:1588-1601
53. Langhorne P, Dennis M. Stroke Units: An Evidence Based Approach. London: BMJ Books; 1998
54. Jorgensen HS, Kammersgaard LP, Houth J, et al. Who benefits from treatment and rehabilitation in a stroke unit? A community-based study. Stroke 2000;31:434-439
55. Stroke Unit Trialists' Collaboration. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. BMJ 1997;314:1151-1159
56. Johnston KC, Li JY, Lyden PD, et al. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke 1998;29:447-453
57. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 2003;60:620-625
58. Evans A, Perez I, Harraf F, et al. Can differences in management processes explain different outcomes between stroke unit and stroke-team care? Lancet 2001;358:1586-1592
59. Alberts MJ, Hademenos G, Latchaw RE, et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000;283:3102-3109
60. Kidwell CS, Shephard T, Tonn S, et al. Establishment of primary stroke centers: a survey of physician attitudes and hospital resources. Neurology 2003;60:1452-1456
61. Alberts MJ, Latchaw RE, Selman WR, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005;36:1597-1616
62. Dion JE. Management of ischemic stroke in the next decade: stroke centers of excellence. J Vasc Interv Radiol 2004;15: S133-S141
63. Schwamm LH. Get with the guidelines stroke: baseline data on secondary prevention. Stroke 2003;34:288 (Abstract)
64. LaBresh KA. Does "get with the guidelines" improve secondary prevention in patients hospitalized with acute stroke or TIA? Stroke 2005;36:454 (Abstract)
65. Schwamm LH. "Get with the guidelines" improves acute intervention in patients hospitalized with ischemic stroke or TIA. Stroke 2005;36:436 (Abstract)